#API Business
Explore articles tagged with API Business
A New Chapter in Europe
HRV Pharma has entered the European finished formulations market through its acquisition of Germany-based Phatebo. The move gives HRV an established pharmaceutical business with wholesale authorisation, good distribution practice systems and an existing customer base, complementing its global API portfolio.
Two Layers, One Value Chain
HRV Pharma is expanding across two layers of the pharmaceutical value chain through its acquisition of Phatebo GmbH. The combination brings together HRV's global API partner network and Phatebo's licensed European clinical trial supply and pharmaceutical distribution capabilities, while retaining the asset-light business model.
A Foray Into European Markets
HRV Pharma is expanding into European markets through the planned acquisition of Germany-based Phatebo GmbH. The deal provides an entry into finished formulations, clinical trial supply and established pharmaceutical distribution capabilities, including a German wholesale authorisation and long-standing relationships with clinical trial sponsors.